New pharmacologic approaches in the management of osteoarthritis (Q37760150)

From Wikidata

Jump to navigation Jump to search

scientific article published on August 2010

edit

Language	Label	Description	Also known as
English	New pharmacologic approaches in the management of osteoarthritis	scientific article published on August 2010

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20496424

retrieved

22 August 2017

review article

1 reference

stated in

Europe PubMed Central

title

New pharmacologic approaches in the management of osteoarthritis (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20496424

retrieved

22 August 2017

main subject

osteoarthritis

0 references

pharmacology

1 reference

based on heuristic

inferred from title

author name string

Thomas J Schnitzer

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20496424

retrieved

22 August 2017

publication date

1 August 2010

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20496424

retrieved

22 August 2017

published in

Arthritis Care and Research

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20496424

retrieved

22 August 2017

volume

62

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20496424

retrieved

22 August 2017

issue

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20496424

retrieved

22 August 2017

page(s)

1174-1180

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20496424

retrieved

22 August 2017

cites work

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FACR.20260

retrieved

21 January 2018

The discovery of nitric oxide as the endogenous nitrovasodilator

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FACR.20260

retrieved

21 January 2018

Treating osteoarthritis with cyclooxygenase-2-specific inhibitors: what are the benefits of avoiding blood pressure destabilization?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FACR.20260

retrieved

21 January 2018

Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FACR.20260

retrieved

21 January 2018

Identifiers

DOI

10.1002/ACR.20260

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20496424

retrieved

22 August 2017

PubMed publication ID

20496424

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20496424

retrieved

22 August 2017

ResearchGate publication ID

44624522

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37760150&oldid=2217752230"